Clinically, IGF-1 and derivatives are used to treat patients who suffer from muscle wasting due to conditions like HIV, as well as patients with hormonal disorders [2]
It has been shown that TRZ improves neuronal survival in different neurodegenerative diseases, including AD, by activating brain GIP receptors, which enhance transduction pathways involved in neural growth (Talbot 2014)
This initial phase feels motivating because the scale moves noticeably, though it's important to recognize that much of this reflects changes in water retention and digestive content rather than fat loss
In this retrospective cohort study of electronic health records (EHRs) from the TriNetX Analytics Network, a global federated health research network of approximately 105.3 million patients from 61 large healthcare organizations in the US, we aimed to assess the associations of semaglutide with both incident and recurrent CUD diagnosis compared to non-GLP-1RA anti-obesity or anti-diabetes medications
Its not a coincidence that early GLP-1 users are also revealing that lack of satiety has a known sensory experience which flips to becoming negative for some users of these drugs